AOD-9604 Dosage Guide
Complete guide to AOD-9604 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
300 mcg – 500 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
12–24 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Research dosing typically ranges from 250-500mcg daily, often split into morning and afternoon doses.
Some protocols use higher doses up to 1mg.
Administration Method
Subcutaneous injection, typically in the abdominal area. Best administered on an empty stomach. Can be combined with exercise for enhanced effects.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.160 ml
Syringe units: 16.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with AOD-9604 defaults. Adjust values as needed.
Side Effects to Monitor
Generally well-tolerated. May cause headaches, injection site reactions, or temporary lethargy. Does not affect blood glucose like full GH.
Safety Considerations & Risks
Limited long-term human data. Failed to receive FDA approval as an anti-obesity drug. Quality and purity concerns with research-grade products.